⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

ILMN

Illumina, Inc.

Healthcare · Diagnostics & Research

269.42USD

+0.0200 (+0.01%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on ILMN.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$1.36▼$1.3610
Next quarter$1.53▲$1.520
Current year$5.36▲$5.2320
Next year$6.13▲$5.9321

Recent quarters

Beat in 4 of the last 4

QuarterEstimateActualSurprise
2026-06-30$1.23$1.31+0.08 (+6.8%)
2026-03-31$1.05$1.15+0.10 (+9.0%)
2025-12-31$1.23$1.35+0.12 (+9.7%)
2025-09-30$1.17$1.34+0.17 (+14.7%)

Wall Street coverage

390 ratings from 47 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
Canaccord GenuityMaintainedHold$205 $300Oct 19, 2026
TD CowenMaintainedHold$210 $270Oct 13, 2026
BarclaysMaintainedUnderweight$160 $200Oct 7, 2026
RBC CapitalMaintainedOutperform$230 $310Oct 5, 2026
GuggenheimMaintainedBuy$226 $305Oct 1, 2026
Leerink PartnersMaintainedOutperform$220 $300Sep 29, 2026
Piper SandlerMaintainedOverweight$225 $305Sep 28, 2026
UBSUpgraded from NeutralBuy$135 $260Sep 9, 2026
Argus ResearchMaintainedBuy$180 $235Sep 3, 2026
Canaccord GenuityMaintainedHold$190 $205Aug 3, 2026
CitigroupMaintainedSell$95 $113Aug 3, 2026
Piper SandlerReiteratedOverweight$200 $225Aug 3, 2026
RBC CapitalMaintainedOutperform$170 $230Jul 31, 2026
JP MorganMaintainedOverweight$220 $230Jul 31, 2026
TD CowenMaintainedHold$192 $210Jul 31, 2026
GuggenheimMaintainedBuy$200 $226Jul 31, 2026
StifelMaintainedBuy$155 $225Jul 31, 2026
BarclaysMaintainedUnderweight$145 $160Jul 31, 2026
Leerink PartnersMaintainedOutperform$175 $210Jul 17, 2026
Canaccord GenuityMaintainedHold$140 $190Jul 14, 2026
Evercore ISI GroupMaintainedOutperform$155 $200Jul 6, 2026
Piper SandlerMaintainedOverweight$170 $200Jul 1, 2026
GuggenheimMaintainedBuy$180 $200Jun 29, 2026
BarclaysMaintainedUnderweight$122 $145Jun 24, 2026
JP MorganUpgraded from NeutralOverweight$125 $185Jun 10, 2026

Insider transactions

99 filings from 28 insiders · 16 buy / 14 sell over 6m

Officers and directors of ILMN, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
Thaysen JacobDirector; Officer, Chief Executive OfficerTax1.3k$293.69$383kOct 5, 2026
Meister Keith A.DirectorGrant107$219.80$24kSep 30, 2026
Ullem Scott B.DirectorGrant113$219.80$25kSep 30, 2026
Coletti Julie AnnOfficer, Chief Legal OfficerGrantPerformance Shares5.3k——Sep 8, 2026
Coletti Julie AnnOfficer, Chief Legal OfficerGrantPerformance Shares5.3k——Sep 8, 2026
Coletti Julie AnnOfficer, Chief Legal OfficerGrant14.2k——Sep 8, 2026
Coletti Julie AnnOfficer, Chief Legal OfficerGrant4.5k——Sep 8, 2026
Barnard StevenOfficer, SVP, Chief Technology OfficerTax408$211.06$86kSep 5, 2026
Meister Keith A.DirectorSellindirect11.4k$219.18$2.49MSep 4, 2026
Meister Keith A.DirectorSellindirect100.7k$218.39$21.98MSep 4, 2026
Meister Keith A.DirectorSellindirect7.5k$217.28$1.63MSep 4, 2026
Meister Keith A.DirectorSellindirect10.0k$221.55$2.21MSep 3, 2026
Meister Keith A.DirectorSellindirect6.7k$220.17$1.47MSep 3, 2026
Meister Keith A.DirectorSellindirect13.7k$219.41$3.01MSep 3, 2026
Meister Keith A.DirectorSellindirect9.7k$218.33$2.12MSep 3, 2026
Meister Keith A.DirectorSellindirect14.2k$217.29$3.08MSep 3, 2026
Meister Keith A.DirectorSellindirect13.3k$216.38$2.87MSep 3, 2026
Meister Keith A.DirectorSellindirect8.4k$215.20$1.82MSep 3, 2026
Meister Keith A.DirectorSellindirect10.6k$213.73$2.27MSep 2, 2026
Meister Keith A.DirectorSellindirect57.5k$213.20$12.26MSep 2, 2026

Analyst Notes

Sign in to write

No analyst notes on ILMN yet.

Analyst Ratings

20 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current46722Hold2.62
1 mo ago47622Hold2.57
2 mo ago46613Hold2.65
3 mo ago46513Hold2.63
Price target$248.90$113.00 – $365.00
-7.6% to target

Top voices on ILMN

Members whose judged calls on ILMN have played out most reliably.

No settled calls on ILMN yet. Nobody has filed a call with a deadline on it.

A member is listed once they have three judged calls on a name.

Sign in to make a call

A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.

A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.

A member’s prediction, judged on price history · not investment advice